SI
GNMK

Stephens Inc’s GenMark Diagnostics, Inc GNMK Stock Holding History

Stephens Inc’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,323
Closed -$75K – 1215
2020
Q1 		$75K Sell
18,323
-2,242
-11% -$10.5K ﹤0.01% 1001
2019
Q4 		$99K Sell
20,565
-3,008
-13% -$16.6K ﹤0.01% 1068
2019
Q3 		$143K Sell
23,573
-13,222
-36% -$82.5K ﹤0.01% 1074
2019
Q2 		$239K Buy
36,795
+7,193
+24% +$50.7K 0.01% 1010
2019
Q1 		$210K Buy
29,602
+15,614
+112% +$103K 0.01% 1037
2018
Q4 		$68K Sell
13,988
-5,279
-27% -$27.5K ﹤0.01% 1068
2018
Q3 		$142K Buy
+19,267
New +$141K ﹤0.01% 1092

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Stephens Inc's GNMK Position: Q2 2020 in Review

Stephens Inc sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2020, closing a stake of 18,323 shares — an estimated $75K sold.

Stephens Inc first reported a position in GNMK in Q3 2018 and held it in 7 quarters. The position peaked at $239K in Q2 2019. 148 funds tracked by Wall St. Rank hold GNMK as of Q2 2020.

  • Stephens Inc reported no remaining GenMark Diagnostics, Inc position as of Q2 2020 after selling out during the quarter.
  • Stephens Inc sold 18,323 GenMark Diagnostics, Inc shares in Q2 2020, an estimated $75K.
  • Stephens Inc first reported a position in GenMark Diagnostics, Inc in Q3 2018 and held it in 7 quarters.
  • Stephens Inc's GenMark Diagnostics, Inc position peaked at $239K in Q2 2019.
  • 148 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2020.

Based on Stephens Inc's 13F filing for Q2 2020, filed 24 Aug 2020.